1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 671 F.Supp.3d
  5. 671 F.Supp.3d 489 (2023)
 

AZURITY PHARMACEUTICALS v. ALKEM LABORATORIES

Civil Action No. 20-cv-1094.

671 F.Supp.3d 489 (2023)

AZURITY PHARMACEUTICALS, INC., Plaintiff, v. ALKEM LABORATORIES LTD., Defendant.

United States District Court, D. Delaware.

Filed May 4, 2023.

Attorney(s) appearing for the Case

Jack B. Blumenfeld, Megan Elizabeth Dellinger, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE, Wendy L. Devine, Pro Hac Vice, San Francisco, CA, Elham F. Steiner, Pro Hac Vice, James P.H. Stephens, Pro Hac Vice, for Plaintiff.

Daniel Taylor, Eve H. Ormerod, Neal C. Belgam, Smith, Katzenstein & Jenkins LLP, Wilmington, DE, Joshua I. Miller, Pro Hac Vice, Washington, DC, Alan H. Pollack, Pro Hac Vice, Beth C. Finkelstein, Pro Hac Vice, Constance S. Huttner, Pro Hac Vice, Madison, NJ, for Defendant.

MEMORANDUM OPINION

This lawsuit was brought under the Hatch Waxman Act for patent infringement pursuant to 35 U.S.C. § 271(e)(2)(a). Plaintiff Azurity Pharmaceuticals, Inc. ("Azurity") claims that an Abbreviated New Drug Application (ANDA), submitted by...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases